We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTS:NYSEWatts Water Technologies, Inc. Analysis

Data as of 2026-07-30 - not real-time

$344.20

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Watts Water Technologies has delivered robust double‑digit revenue growth and solid profitability, with margins comfortably above industry averages and a cash‑rich balance sheet that keeps debt at a modest level. Recent earnings have beaten expectations, driven by strong demand from data‑center and water‑infrastructure projects, and the dividend remains sustainable thanks to a low payout ratio and strong operating cash flow. Technically, the stock trades above its short‑ and medium‑term moving averages, indicating a bullish trend, but the MACD has turned bearish and volume is slipping, suggesting short‑term caution.
Valuation metrics show the market price is well above the DCF‑derived fair value and carries a forward PE that, while improving, still sits slightly above the sector average. The modest upside implied by analyst targets, combined with high 30‑day volatility and a beta below one, points to a stock that is currently overvalued but underpinned by durable growth drivers. Investors should weigh the strong fundamentals and defensive dividend against the near‑term technical weakness and limited upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat and strong cash flow
  • Bearish MACD divergence and decreasing volume
  • Price near established support level

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained revenue growth and expanding data‑center demand
  • Modest upside relative to analyst price targets
  • Overvalued relative to DCF fair value but improving forward PE

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Secular tailwinds in water infrastructure and energy efficiency
  • Strong balance sheet with low leverage and sustainable dividend
  • Defensive exposure across multiple geographic markets

Key Metrics & Analysis

Financial Health

Revenue Growth21.40%
Profit Margin14.32%
P/E Ratio31.5
ROE18.94%
ROA11.49%
Debt/Equity14.55
P/B Ratio5.5
Op. Cash Flow$364.7M
Free Cash Flow$184.4M
Industry P/E30.6

Technical Analysis

TrendBullish
RSI49.6
Support$334.12
Resistance$385.01
MA 20$348.69
MA 50$336.95
MA 200$303.59
MACDBearish
VolumeDecreasing
Fear & Greed Index90.21

Valuation

Fair Value$172.69
Target Price$358.33
Upside/Downside4.11%
GradeOvervalued
TypeGrowth
Dividend Yield0.65%

Risk Assessment

Beta0.91
Volatility43.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.